Cargando…
Metabolic Overlap between Alzheimer’s Disease and Metabolic Syndrome Identifies the PVRL2 Gene as a New Modulator of Diabetic Dyslipidemia
Background: Alzheimer’s disease (AD) and type 2 diabetes mellitus (T2DM) share metabolic alterations such as abnormal insulin and lipid metabolism and have some common genetic factors such as APOE genotype. Taking this into account, we hypothesized that we could identify common genetic factors invol...
Autores principales: | Guardiola, Montse, Muntané, Gerard, Martínez, Iris, Martorell, Lourdes, Girona, Josefa, Ibarretxe, Daiana, Plana, Núria, Bullido, María J., Vilella, Elisabet, Ribalta, Josep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139078/ https://www.ncbi.nlm.nih.gov/pubmed/37108578 http://dx.doi.org/10.3390/ijms24087415 |
Ejemplares similares
-
Circulating PCSK9 levels and CETP plasma activity are independently associated in patients with metabolic diseases
por: Girona, Josefa, et al.
Publicado: (2016) -
PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk
por: Rehues, Pere, et al.
Publicado: (2023) -
HDL Triglycerides: A New Marker of Metabolic and Cardiovascular Risk
por: Girona, Josefa, et al.
Publicado: (2019) -
Unveiling the Role of the Fatty Acid Binding Protein 4 in the Metabolic-Associated Fatty Liver Disease
por: Moreno-Vedia, Juan, et al.
Publicado: (2022) -
Glycoprotein Profile Measured by a (1)H-Nuclear Magnetic Resonance Based on Approach in Patients with Diabetes: A New Robust Method to Assess Inflammation
por: Amigó, Núria, et al.
Publicado: (2021)